| Pharmacovigilance Programme of India: Recent developments and future perspectives V Kalaiselvan, P Thota, GN Singh Indian journal of pharmacology 48 (6), 624-628, 2016 | 124 | 2016 |
| Biosynthesis of silver nanoparticles from Aspergillus niger and evaluation of its wound healing activity in experimental rat model V Kalaiselvan, A Rajasekaran Int. J. Pharm. Tech. Res 4, 1523-1529, 2009 | 108 | 2009 |
| Current knowledge and future direction of research on soy isoflavones as a therapeutic agents V Kalaiselvan, M Kalaivani, A Vijayakumar, K Sureshkumar, ... Pharmacognosy Reviews 4 (8), 111, 2010 | 88 | 2010 |
| Pharmacovigilance in India: present scenario and future challenges V Kalaiselvan, S Srivastava, A Singh, SK Gupta Drug safety 42, 339-346, 2019 | 77 | 2019 |
| Trigonella foenum-graecum (Fenugreek) Protects Against Selenite-Induced Oxidative Stress in Experimental Cataractogenesis SK Gupta, V Kalaiselvan, S Srivastava, R Saxena, SS Agrawal Biological trace element research 136, 258-268, 2010 | 68 | 2010 |
| Adverse drug reactions reporting culture in Pharmacovigilance Programme of India V Kalaiselvan, T Prasad, A Bisht, S Singh, GN Singh Indian Journal of Medical Research 140 (4), 563-564, 2014 | 57 | 2014 |
| Health benefits and clinical impact of major nutrient, red yeast rice: a review M Kalaivani, R Sabitha, V Kalaiselvan, A Rajasekaran Food and Bioprocess Technology 3, 333-339, 2010 | 56 | 2010 |
| Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies SK Gupta, V Kalaiselvan, S Srivastava, SS Agrawal, R Saxena Journal of Ayurveda and Integrative Medicine 1 (4), 280, 2010 | 55 | 2010 |
| Quality assessment of different marketed brands of Dasamoolaristam, an Ayurvedic formulation V Kalaiselvan, AK Shah, FB Patel, CN Shah, M Kalaivani, A Rajasekaran International journal of Ayurveda research 1 (1), 10, 2010 | 49 | 2010 |
| Implementation of adverse event reporting for medical devices, India S Shukla, M Gupta, S Pandit, M Thomson, A Shivhare, V Kalaiselvan, ... Bulletin of the World Health Organization 98 (3), 206, 2020 | 47 | 2020 |
| Ajmalicine and reserpine: Indole alkaloids as multi-target directed ligands towards factors implicated in Alzheimer’s disease P Kashyap, V Kalaiselvan, R Kumar, S Kumar Molecules 25 (7), 1609, 2020 | 40 | 2020 |
| Phyllanthus species: scientific evaluation and medicinal applications R Kuttan, KB Harikumar CRC Press, 2011 | 40 | 2011 |
| System of adverse drug reactions reporting: What, where, how, and whom to report? V Kalaiselvan, P Kumar, P Mishra, G Singh Indian Journal of Critical Care Medicine 19 (9), 564, 2015 | 38 | 2015 |
| Adverse reactions to contrast media: An analysis of spontaneous reports in the database of the pharmacovigilance programme of India V Kalaiselvan, S Sharma, GN Singh Drug safety 37, 703-710, 2014 | 38 | 2014 |
| Effectiveness and safety of bedaquiline under conditional access program for treatment of drug –resistant tuberculosis in India: An interim analysis. SS 3. Salhotra VS, Sachdeva KS, Neelima K, Malik P, Ranjani R ... Indian Journal of Tuberculosis, 2019 | 37* | 2019 |
| Helpline facility to assist reporting of adverse drug reactions in India V Kalaiselvan, P Mishra, GN Singh WHO South-East Asia Journal of Public Health 3 (2), 194, 2014 | 36 | 2014 |
| Implementation of self reporting pharmacovigilance in anti tubercular therapy using knowledge based approach PS Abideen, K Chandrasekaran, VA Uma Maheswaran, V Kalaiselvan J Pharmacovigilance 1 (101), 2, 2013 | 34 | 2013 |
| Pharmacovigilance programme of India V Kalaiselvan, J Prakash, GN Singh Arch Pharm Pract 3 (3), 229-232, 2012 | 34 | 2012 |
| Materiovigilance programme of India (MVPI): A step towards patient safety for medical devices P Kumar, V Kalaiselvan, I Kaur, P Thota, GN Singh Eur J Biomed Pharm Sci 12 (7), 497-501, 2016 | 32 | 2016 |
| Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy R Saxena, D Singh, S Phuljhele, V Kalaiselvan, S Karna, R Gandhi, ... Indian journal of ophthalmology 69 (12), 3734-3739, 2021 | 27 | 2021 |
Dr. Prasad ThotaIndian Pharmacopoeia Commission在 gov.in 的电子邮件经过验证
